Cargando…
Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia. Accumulating experimental evidence shows the important linkage between tumor necrosis factor-α (TNF) and AD, but the exact role of TNF in AD is still not completely understood. Although TNF-in...
Autores principales: | Ortí-Casañ, Natalia, Wu, Yingying, Naudé, Petrus J. W., De Deyn, Peter P., Zuhorn, Inge S., Eisel, Ulrich L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369349/ https://www.ncbi.nlm.nih.gov/pubmed/30778285 http://dx.doi.org/10.3389/fnins.2019.00049 |
Ejemplares similares
-
A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer’s disease mouse model
por: Ortí-Casañ, Natalia, et al.
Publicado: (2022) -
Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer’s Disease Mouse Model with Humanized TNF Receptor 2
por: Ortí-Casañ, Natalia, et al.
Publicado: (2023) -
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration
por: Ortí-Casañ, Natalia, et al.
Publicado: (2023) -
Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model
por: Dekens, Doortje W., et al.
Publicado: (2018) -
Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer’s Disease (AD) Brain Regions: Differential Findings in AD with and without Depression
por: Dekens, Doortje W., et al.
Publicado: (2016)